Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
Phase of Trial: Phase I/II
Latest Information Update: 27 Nov 2017
Price : $35 *
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 22 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 02 Dec 2014 Two treatment arms have been added.(Placebo single dose and Roflumilast 500µg single dose) as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned number of patients changed from 40 to 30 as reported by ClinicalTrials.gov record.